Serotonergic involvement in levodopa-induced dyskinesias in Parkinson’s disease
Authors:
- Perdita A. CheshirePCPerdita A. Cheshire
- David R. WilliamsDWDavid R. Williams
- 1 March 2012
- journal article
- review article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 19 (3) , 343-348
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Milestones in Parkinson's disease therapeuticsMovement Disorders, 2011
- Long‐term antidyskinetic efficacy of amantadine in Parkinson's diseaseMovement Disorders, 2010
- Treatment of levodopa-induced motor complicationsMovement Disorders, 2008
- Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestationsMovement Disorders, 2005
- Levodopa and the Progression of Parkinson's DiseaseNew England Journal of Medicine, 2004
- Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literatureMovement Disorders, 2001
- Health-Related Quality of Life and Healthcare Utilisation in Patients with Parkinson??s DiseasePharmacoEconomics, 2001
- Dyskinesias and motor fluctuations in Parkinson's diseaseBrain, 2000
- What contributes to quality of life in patients with Parkinson's disease?Journal of Neurology, Neurosurgery & Psychiatry, 2000
- Risk factors for levodopa-induced dyskinesias in Parkinson's diseaseJournal of Neurology, 1999